Kexin Liu
- Molecular Biology top 2%
- Oncology top 1%
- Pharmacology top 0.1%
- Epidemiology top 2%
- Pharmacology top 1%
- Topics
- Drug Transport and Resistance Mechanisms (77 papers)Liver Disease Diagnosis and Treatment (29 papers)Pharmacological Effects and Toxicity Studies (21 papers)
- Cited by
- PharmacologyOncologyHepatology
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Kexin Liu
310 papers receiving 8.2k citations
Peers
Comparison fields: 5 of 160
- Molecular Biology 3.5k
- Oncology 1.8k
- Pharmacology 1.2k
- Epidemiology 986
- Pharmacology 681
Countries citing papers authored by Kexin Liu
This map shows the geographic impact of Kexin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kexin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kexin Liu more than expected).
Fields of papers citing papers by Kexin Liu
This network shows the impact of papers produced by Kexin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kexin Liu. The network helps show where Kexin Liu may publish in the future.
Co-authorship network of co-authors of Kexin Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Kexin Liu. A scholar is included among the top collaborators of Kexin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kexin Liu. Kexin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 13 | |
| 10 | 9 | |
| 11 | 25 | |
| 12 | 9 | |
| 13 | 27 | |
| 14 | 16 | |
| 15 | 57 | |
| 16 | 21 | |
| 17 | 10 | |
| 18 | 14 | |
| 19 | 126 | |
| 20 | [The drug-drug interaction mediated by efflux transporters and CYP450 enzymes]. | 6 |
About Kexin Liu
Kexin Liu is a scholar working on Pharmacology, Oncology and Hepatology, having authored 325 papers that have together received 8.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (77 papers), Liver Disease Diagnosis and Treatment (29 papers) and Pharmacological Effects and Toxicity Studies (21 papers). The work is most often cited by research in Pharmacology (1.2k citations), Oncology (1.8k citations) and Hepatology (413 citations). Kexin Liu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Changyuan Wang, Huijun Sun, Jinyong Peng, Qiang Meng, Xiaokui Huo, Zhihao Liu, Yan Qi, Lina Xu, Pengyuan Sun and Xiaodong Ma. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.